Suven Pharmaceuticals Ltd Quarterly Results

Gross Sales

555.57

549.31

840.42

307.15

603.77

Excise Duty

0

0

0

0

0

Net Sales

555.57

549.31

840.42

307.15

603.77

Other Operating Income

0

0

0

0

0

Other Income

15.6

14.17

12.05

15.71

16.19

Total Income

571.17

563.48

852.47

322.86

619.96

Total Expenditure

434.62

445.4

626.98

189.45

398.4

PBIDT

136.55

118.08

225.49

133.41

221.56

Interest

8.76

10.18

10.45

3.33

9.61

PBDT

127.79

107.9

215.04

130.08

211.95

Depreciation

44.02

45.14

54.17

20.35

37.79

Minority Interest Before NP

0

0

0

0

0

Tax

27.04

18.18

31.9

41.6

43.91

Deferred Tax

-9.66

-1.82

11.82

-15.16

-7.99

Reported Profit After Tax

66.39

46.4

117.15

83.29

138.24

Minority Interest After NP

-7.69

-2.48

-3.28

0.41

-0.23

Net Profit after Minority Interest

74.08

48.88

120.43

82.88

138.47

Extra-ordinary Items

0

-5.75

-11.49

0

0

Adjusted Profit After Extra-ordinary item

74.08

54.63

131.92

82.88

138.47

EPS (Unit Curr.)

1.94

1.28

3.16

3.26

3.63

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

38.26

38.26

25.46

25.46

25.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

24.57

21.49

26.83

43.43

36.69

PBDTM(%)

23

19.64

25.58

42.35

35.1

PATM(%)

11.94

8.44

13.93

27.11

22.89